Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by Smitty2000on Feb 11, 2017 6:43pm

212 Views

Post# 25833128

RE:RE:RE:CEO

lets just hope the news is of some interest to the market. we haven't seen the boutique pr firm they hired do much to move the sp or the san francisco presentation.

kaos12 wrote: I talked to him yesterday and yes we should be getting news shortly. I believe in less than two weeks. Also they may have a few more irons in the fire. He was very pleased or quite "up" with the news that is forthcoming. Personally, I think this news should push us upwards nicely considering my conversation with him. Nice and personable guy. GLTA

Bullboard Posts

Sirios Resource discovers visible gold in Quebec